Application of RORA (retinoid-related orphan receptor alpha) gene in acute myocardial infarction risk prediction markers

The invention discloses application of RORA (retinoid-related orphan receptor alpha) gene in acute myocardial infarction risk prediction markers, is intended to make clear prediction and estimation onthe risk for the patient with coronary heart disease to suffer myocardial infarction, and relates to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TAN BUCHUAN, YANG PING, MENG HEYU, WANG XUE, GAO GUANGYUAN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses application of RORA (retinoid-related orphan receptor alpha) gene in acute myocardial infarction risk prediction markers, is intended to make clear prediction and estimation onthe risk for the patient with coronary heart disease to suffer myocardial infarction, and relates to the field of genetic diagnosis and biomedicine, in particular to peripheral blood myocardial infarction marker detection and application thereof, more in particular to application of genetic expression products and biological preparations in myocardial infarction prediction and diagnostic and therapeutic drugs. The invention belongs to the technical field of genetic diagnosis and biological pharmacy. 本发明公开一种提供了RORA基因在急性心肌梗死风险预测标记物中的用途，为明确冠心病患者患心肌梗死疾病的风险预测评估，涉及基因诊断和生物医药领域，具体涉及一种外周血心肌梗死标志物检测及其应用，更具体是指基因表达产物和生物制剂在制备心肌梗死预测和诊疗药物中的应用，属于基因诊断和生物制药技术领域。